Balance sheetDanger
자본잠식 — 자본총계가 마이너스입니다. 부실 위험을 나타내는 사실 지표입니다.
Nasus Pharma Ltd.
NSRX · NYSE Amex$3.73-0.40%
2026-09-04 closeNasus Pharma Ltd. last closed at $3.73 (-0.40%) on 2026-09-04. Listed on NYSE Amex; price, financials and dividends update daily after market close.
Loading chart…
Close
No active signal.
New high + volume — the real recordrecord · not a prediction
Last 30 sessions
277 picks
Next-day win rate
44.2%
Avg next-day
-0.28%
vs market
-0.51%p
Every new-high-plus-volume pick we actually published (US market) — not this stock alone.
Signal history
| Date | Signal | +20 trading days |
|---|---|---|
A record, not a prediction.
How this is calculated
"·" means fewer than 20 trading days have passed since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.
Trade plan
Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.
A calculator · not advice or a guarantee
Financials & valuation at a glance
Past reported results · not investment advice
More — deeper indicators
Financial safety
Reference indicatorAs of 2024Distress zoneFinancial-metric reference signal
Altman Z'' zoneZ'' -109.95
Distress
Grey
Safe
- Altman Z''
- -109.95
- Beneish M-Score
- —
- Sloan accrual
- -240.28%
Statistical flag unavailable
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Earnings quality · Piotroski F-Score
1/9Weak
Piotroski measures year-over-year financial improvement, not absolute quality.
Financial improvement score1/9
Profitability
- Positive ROANot passed
- Positive OCFNot passed
- Improving ΔROANot passed
- Accruals (OCF > net income)Pass
Leverage & liquidity
- Lower debtNot passed
- Higher current ratioNot passed
- No new sharesNot passed
Efficiency
- Higher gross marginNot passed
- Higher asset turnoverNot passed
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Forensic signals
Anomaly and structural signals observed in the financial statements.
Factual information, not investment advice.
Connections
AI-extracted related companies · for reference
Suppliers
Competitors
Same theme
희귀질환 치료제비강 분무형 약물전달
Recent filings
Filings for overseas stocks are on the way. For now we cover Korean stocks only.
About Nasus Pharma Ltd.
- What technical signals does Nasus Pharma Ltd. (NSRX) have?
- Nasus Pharma Ltd. current technical signals: no active technical signal.
- Is Nasus Pharma Ltd. a cup-and-handle pattern?
- No. Nasus Pharma Ltd. has no valid cup-and-handle signal right now.
- What are Nasus Pharma Ltd.'s financials and valuation?
- Nasus Pharma Ltd.'s income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Quantus Signal · live data · not investment advice · Privacy Policy